ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Reduce Costs And Improve Adherence For Self-Administration Of Biologics

  There is a growing trend toward wearable injectors for bolus delivery in order to help improve adherence and lower the costs of therapy. 

• Accelerating The Development Of Oncology Medicines

  Oncology drug development has seen a significant shift in focus, as molecule chemistries and drug technologies have improved. Explore five areas for consideration and the potential emerging solutions.

• Making The Right Choice For Multiparticulate Modified Release Dosage Forms

  Wurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.

• Key Considerations For Selecting Flexible Fillers

  Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.

• Reducing Environmental Impact At All Stages Of The Medicine Journey

  Explore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product to patients with greener logistics.

• Spray Drying: Advantages And Disadvantages

  When it comes to formulation development, pharmaceutical spray drying is one of the most versatile solutions. Review a detailed look at the steps involved in spray drying and the benefits and downsides.

• Device Design For Usability And Risk Reduction

  Growing use of large‑volume subcutaneous therapies is increasing demand for wearable injectors that reduce user error, simplify preparation, and enhance safety through human‑factors‑focused design.

• Establishing And Safeguarding Shelf Life In Combination Products

  Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.

• New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory Pathway

  Discover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and stakeholder engagement is essential.

• Improved Biomanufacturing Processes And Drug Product Stability

  Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.